期刊信息查詢系統

期刊標題檢索 CELL DEATH DIS 最新評論: It has been three weeks since I applied, but I am still under conside... (2023-12-04)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Cell Death & Disease]您好，您是該頁面的第 388344 位訪客。

期刊簡介

期刊名稱

Cell Death & Disease
LetPub Score

7.7

52 ratings

Rate

Reputation

8.2

Influence

6.9

Speed

9.0

期刊簡稱

CELL DEATH DIS

ISSN

2041-4889

h-index

CiteScore

SJR

SNIP

CiteScore Rank

15.10

2.447

1.450

Subject field	Quartiles	Rank	Percentile
Category: Neuroscience Subcategory: Cellular and Molecular Neuroscience	Q1	7 / 97
Category: Neuroscience Subcategory: Cell Biology	Q1	29 / 285
Category: Neuroscience Subcategory: Cancer Research	Q1	26 / 230
Category: Neuroscience Subcategory: Immunology	Q1	29 / 236

自引率 (2023-2024)

2.50%自引率趨勢

掲載範囲

Brought to you by the editorial team of Cell Death & Differentiation, Cell Death & Disease is a peer-reviewed online journal in the field of translational cell death. It seeks to promote diverse and integrated areas of experimental and internal medicine with its specialties, including cancer, immunity and neuroscience. It is now also accepting articles in a new area: cancer metabolism.

官方網站

http://www.nature.com/cddis/

在線稿件提交

http://mts-cddis.nature.com/cgi-bin/main.plex

開放訪問

Yes

出版商

Springer Nature

主題領域

CELL BIOLOGY

出版國/地區

ENGLAND

發行頻率

創刊年

2010

每年文章數

808每年文章數趨勢

黃金OA百分比

99.69%

OA Related Info

APC: Yes（ GBP3290; USD4790; EUR3890; ）
APC waiver：Check Notes
Other charges: No
Keywords: apoptosis、cell death、cancer、immunology、neurodegeneration、cell biology
Useful LinksAims & Scope Author Instructions Editorial Board Anonymous peer review

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q1

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
CELL BIOLOGY	SCIE	Q1	33/205

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2041-4889%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: Average 2 Month(s)

競爭力 *

來自作者的數據: Difficult

參考鏈接

相關期刊	【Cell Death & Disease】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
NATURE REVIEWS MOLECULAR CELL BIOLOGY	H-index: 386 CiteScore: 173.60
NATURE REVIEWS MICROBIOLOGY	H-index: 250 CiteScore: 74.00
CELL	H-index: 705 CiteScore: 110.00
NATURE REVIEWS GENETICS	H-index: 320 CiteScore: 57.40
NATURE METHODS	H-index: 257 CiteScore: 58.70
NATURE BIOTECHNOLOGY	H-index: 399 CiteScore: 63.00
NATURE GENETICS	H-index: 527 CiteScore: 43.00
CELL RESEARCH	H-index: 143 CiteScore: 53.90
Cell Metabolism	H-index: 219 CiteScore: 48.60
FUNGAL DIVERSITY	H-index: 80 CiteScore: 44.80

學科內最受檢索的期刊	頁面查看次數
Frontiers in Plant Science	771512
Frontiers in Microbiology	740369
BIOSENSORS & BIOELECTRONICS	613153
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS	570957
PeerJ	438469
BMC GENOMICS	432070
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY	409491
Cell Reports	383712
APPLIED AND ENVIRONMENTAL MICROBIOLOGY	363401
NUCLEIC ACIDS RESEARCH	338136

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Cell Death & Disease] 的評論	撰寫評論

作者: 缪斯領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-12-04 15:11:29 評論於 It has been three weeks since I applied, but I am still under consideration. Have you received any updates, Luoluo? (0) 讚！ \| 缪斯
作者: bulnsnow 領域: 医学審稿時間: 4.0 month(s) 結果: 修改後接受撰寫評論	2023-11-16 18:46:09 評論於 Come on! (0) 讚！ \| bulnsnow
作者: shangkedu 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-11-16 06:24:18 評論於 We switched from CDD to CDDis, but it's been 15 days and we still haven't been assigned a receiving editor. What's going on? (0) 讚！ \| shangkedu
作者: GYYFJP 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-06-19 20:43:14 評論於 Does this journal not have "Under Review"? (0) 讚！ \| GYYFJP
作者: 科研大白領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-11-10 17:03:32 評論於投 in June, returned for repairs in July, conducted additional experiments in the meantime for two months. It has been a month since the first return for repairs, and it has been constantly under consideration, causing anxiety. Why is the reviewing process so slow for the return for repairs? (0) 讚！ \| 科研大白
作者: chamomile1113 領域: 生物学審稿時間: 3.0 month(s) 結果: 修改後接受撰寫評論	2022-07-19 11:23:45 評論於 The editor has strict control over the quality of the article, emphasizing the quality of data and novelty. The review comments are objective and the entire process takes nearly half a year. (1) 讚！ \| chamomile1113
作者: 爆热辣椒尖尖領域: 医学審稿時間: 2.0 month(s) 結果: 待定＆不明撰寫評論	2021-05-07 09:32:57 評論於 Doesn't it only provide one opportunity for revision? (0) 讚！ \| 爆热辣椒尖尖
作者: cjsasuke 領域: 医学審稿時間: 1.0 month(s) 結果: 修改後接受撰寫評論	2020-07-21 17:18:24 評論於 It was submitted at the end of February, and revisions were required at the end of March. During the period, the status had always been under consideration and the revised manuscript was uploaded at the end of May. The revised manuscripts were resubmitted several times during the period and was accepted in mid-July. It's still pretty good, and I also made up experiments in the middle. (7) 讚！ \| cjsasuke
作者: 科研小白N 領域: 医学審稿時間: 1.0 month(s) 結果: 待定＆不明撰寫評論	2020-06-23 22:47:52 評論於 The article was submitted in February, and three revisions has been made. It has been 12 days after the submission of the third revised manuscript, and the status of decision made has been 4 days. I don’t know how the result is. I am worrying. Will it be rejected after three times of tired revision? (7) 讚！ \| 科研小白N

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Cell Death & Disease] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: 缪斯領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-12-04 15:11:29 評論於 It has been three weeks since I applied, but I am still under consideration. Have you received any updates, Luoluo? (0) 讚！ \| 缪斯
作者: bulnsnow 領域: 医学審稿時間: 4.0 month(s) 結果: 修改後接受撰寫評論	2023-11-16 18:46:09 評論於 Come on! (0) 讚！ \| bulnsnow
作者: shangkedu 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-11-16 06:24:18 評論於 We switched from CDD to CDDis, but it's been 15 days and we still haven't been assigned a receiving editor. What's going on? (0) 讚！ \| shangkedu
作者: GYYFJP 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2023-06-19 20:43:14 評論於 Does this journal not have "Under Review"? (0) 讚！ \| GYYFJP
作者: 科研大白領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2022-11-10 17:03:32 評論於投 in June, returned for repairs in July, conducted additional experiments in the meantime for two months. It has been a month since the first return for repairs, and it has been constantly under consideration, causing anxiety. Why is the reviewing process so slow for the return for repairs? (0) 讚！ \| 科研大白
作者: chamomile1113 領域: 生物学審稿時間: 3.0 month(s) 結果: 修改後接受撰寫評論	2022-07-19 11:23:45 評論於 The editor has strict control over the quality of the article, emphasizing the quality of data and novelty. The review comments are objective and the entire process takes nearly half a year. (1) 讚！ \| chamomile1113
作者: 爆热辣椒尖尖領域: 医学審稿時間: 2.0 month(s) 結果: 待定＆不明撰寫評論	2021-05-07 09:32:57 評論於 Doesn't it only provide one opportunity for revision? (0) 讚！ \| 爆热辣椒尖尖
作者: cjsasuke 領域: 医学審稿時間: 1.0 month(s) 結果: 修改後接受撰寫評論	2020-07-21 17:18:24 評論於 It was submitted at the end of February, and revisions were required at the end of March. During the period, the status had always been under consideration and the revised manuscript was uploaded at the end of May. The revised manuscripts were resubmitted several times during the period and was accepted in mid-July. It's still pretty good, and I also made up experiments in the middle. (7) 讚！ \| cjsasuke
作者: 科研小白N 領域: 医学審稿時間: 1.0 month(s) 結果: 待定＆不明撰寫評論	2020-06-23 22:47:52 評論於 The article was submitted in February, and three revisions has been made. It has been 12 days after the submission of the third revised manuscript, and the status of decision made has been 4 days. I don’t know how the result is. I am worrying. Will it be rejected after three times of tired revision? (7) 讚！ \| 科研小白N

首頁上一頁 1 下一頁末頁 (頁 /1)

Cell Death & Disease

期刊標題檢索 CELL DEATH DIS 最新評論: It has been three weeks since I applied, but I am still under conside... (2023-12-04)

[Cell Death & Disease]您好，您是該頁面的第 388344 位訪客。

開始撰寫 [Cell Death & Disease] 的評論：

Contact us